Primary tabs
The list of publications is indicative and may not include all publications.
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021).
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease..
Arch Med Res. 52(1), 25-37.
(2021).
Cilofexor for the Treatment of Nonalcoholic Steatohepatitis.
Curr Vasc Pharmacol.
(2021).
Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations..
Aliment Pharmacol Ther.
(2021).
Hypophosphatasia..
J Clin Med. 10(23),
(2021).
Commentary: are blood and saliva sources of COVID-19 spread?.
Eur Rev Med Pharmacol Sci. 25(15), 4872-4874.
(2021).
Adult hypophosphatasia treated with reduced frequency of teriparatide dosing..
J Musculoskelet Neuronal Interact. 21(4), 584-589.
(2021).
Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis..
J Gastroenterol Hepatol.
(2021).
Nonalcoholic fatty liver disease: lifestyle and quality of life..
Hormones (Athens).
(2021).
Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension..
Microorganisms. 9(11),
(2021).
Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis..
Metabolism. 121, 154818.
(2021).
Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021).
Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease..
Eur J Pharmacol. 907, 174272.
(2021).
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease..
Minerva Endocrinol (Torino).
(2021).
Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity..
Hepatobiliary Surg Nutr. 9(1), 73-76.
(2020).
Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial..
Medicina (Kaunas). 56(7),
(2020).
Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients..
J Clin Med. 9(4),
(2020).
Combination and sequential treatment in women with postmenopausal osteoporosis..
Expert Opin Pharmacother. 21(4), 477-490.
(2020).
Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis..
Microorganisms. 8(6),
(2020).
Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020).
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents..
Expert Opin Pharmacother. 21(3), 247-251.
(2020).
Pages
- « πρώτη
- ‹ προηγούμενη
- …
- 2
- 3
- 4
- 5
- 6
- …
- επόμενη ›
- τελευταία »